FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040997484> ?p ?o ?g. }

• W2040997484 endingPage "418" @default.
• W2040997484 startingPage "413" @default.
• W2040997484 abstract "Gonadotropin-releasing hormone (GnRH) analogues administered for the treatment of advanced prostatic cancer induce a transient increase in plasma testosterone levels during the first week of treatment, often with a secondary rise in plasma levels of prostatic acid phosphatase and a flareup of disease. To determine whether the antiandrogen nilutamide (Anandron) blocks these effects, we carried out a multicenter, placebo-controlled study of nilutamide in men with prostatic cancer treated with the GnRH analogue buserelin. Thirty-six men with disseminated prostatic cancer and elevated plasma levels of prostatic acid phosphatase were randomly assigned to two groups. Group 1 included 17 men who received buserelin (500 μg daily subcutaneously) and nilutamide (300 mg daily by mouth); group 2 included 19 men treated with buserelin and placebo. Symptoms were assessed, and plasma was collected before treatment, daily for 14 days, and on days 18, 22, and 29 after the initiation of treatment. Bone pain appeared or worsened in 5 of the 17 men in group 1 and in 12 of the 19 men ingroup 2(P<0.05). Acute urinary obstruction occurred in one man in group 2. Despite similar changes in the plasma testosterone levels in both groups, the median concentration of plasma prostatic acid phosphatase decreased almost immediately in group 1, but increased transiently, then decreased on day 14 in group 2. Median levels of prostate-specific antigen decreased immediately in group 1 and decreased on day 8 in group 2. We conclude that nilutamide can prevent the adverse consequences of the buserelin-induced transient rise in plasma testosterone levels in men with advanced prostate cancer treated with a GnRH analogue. (N Engl J Med 1989; 321:413–8.)" @default.
• W2040997484 created "2016-06-24" @default.
• W2040997484 creator A5007870132 @default.
• W2040997484 creator A5009926714 @default.
• W2040997484 creator A5018464917 @default.
• W2040997484 creator A5018541215 @default.
• W2040997484 creator A5019415074 @default.
• W2040997484 creator A5034053309 @default.
• W2040997484 creator A5057383665 @default.
• W2040997484 creator A5063221171 @default.
• W2040997484 creator A5072604716 @default.
• W2040997484 creator A5091894716 @default.
• W2040997484 date "1989-08-17" @default.
• W2040997484 modified "2023-10-01" @default.
• W2040997484 title "Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)" @default.
• W2040997484 cites W108292446 @default.
• W2040997484 cites W1496003929 @default.
• W2040997484 cites W1704810398 @default.
• W2040997484 cites W17530020 @default.
• W2040997484 cites W1974223241 @default.
• W2040997484 cites W1981296018 @default.
• W2040997484 cites W1991022119 @default.
• W2040997484 cites W1998104267 @default.
• W2040997484 cites W2013649849 @default.
• W2040997484 cites W2016016099 @default.
• W2040997484 cites W2022008209 @default.
• W2040997484 cites W2029200805 @default.
• W2040997484 cites W2034318066 @default.
• W2040997484 cites W2044266924 @default.
• W2040997484 cites W2048518849 @default.
• W2040997484 cites W2056059392 @default.
• W2040997484 cites W2060991243 @default.
• W2040997484 cites W2074613446 @default.
• W2040997484 cites W2075991384 @default.
• W2040997484 cites W2101301511 @default.
• W2040997484 cites W2140475850 @default.
• W2040997484 cites W2330292521 @default.
• W2040997484 cites W2405844923 @default.
• W2040997484 cites W2406031689 @default.
• W2040997484 cites W2417667084 @default.
• W2040997484 cites W2426149359 @default.
• W2040997484 cites W2468363389 @default.
• W2040997484 cites W4253882649 @default.
• W2040997484 doi "https://doi.org/10.1056/nejm198908173210701" @default.
• W2040997484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2503723" @default.
• W2040997484 hasPublicationYear "1989" @default.
• W2040997484 type Work @default.
• W2040997484 sameAs 2040997484 @default.
• W2040997484 citedByCount "204" @default.
• W2040997484 countsByYear W20409974842012 @default.
• W2040997484 countsByYear W20409974842013 @default.
• W2040997484 countsByYear W20409974842014 @default.
• W2040997484 countsByYear W20409974842015 @default.
• W2040997484 countsByYear W20409974842016 @default.
• W2040997484 countsByYear W20409974842017 @default.
• W2040997484 countsByYear W20409974842018 @default.
• W2040997484 countsByYear W20409974842019 @default.
• W2040997484 countsByYear W20409974842020 @default.
• W2040997484 countsByYear W20409974842021 @default.
• W2040997484 countsByYear W20409974842022 @default.
• W2040997484 countsByYear W20409974842023 @default.
• W2040997484 crossrefType "journal-article" @default.
• W2040997484 hasAuthorship W2040997484A5007870132 @default.
• W2040997484 hasAuthorship W2040997484A5009926714 @default.
• W2040997484 hasAuthorship W2040997484A5018464917 @default.
• W2040997484 hasAuthorship W2040997484A5018541215 @default.
• W2040997484 hasAuthorship W2040997484A5019415074 @default.
• W2040997484 hasAuthorship W2040997484A5034053309 @default.
• W2040997484 hasAuthorship W2040997484A5057383665 @default.
• W2040997484 hasAuthorship W2040997484A5063221171 @default.
• W2040997484 hasAuthorship W2040997484A5072604716 @default.
• W2040997484 hasAuthorship W2040997484A5091894716 @default.
• W2040997484 hasConcept C121608353 @default.
• W2040997484 hasConcept C126322002 @default.
• W2040997484 hasConcept C126894567 @default.
• W2040997484 hasConcept C134018914 @default.
• W2040997484 hasConcept C141071460 @default.
• W2040997484 hasConcept C142724271 @default.
• W2040997484 hasConcept C170493617 @default.
• W2040997484 hasConcept C197934379 @default.
• W2040997484 hasConcept C204787440 @default.
• W2040997484 hasConcept C27081682 @default.
• W2040997484 hasConcept C2776490512 @default.
• W2040997484 hasConcept C2777230143 @default.
• W2040997484 hasConcept C2777744392 @default.
• W2040997484 hasConcept C2778723060 @default.
• W2040997484 hasConcept C2778938600 @default.
• W2040997484 hasConcept C2779279991 @default.
• W2040997484 hasConcept C2779322244 @default.
• W2040997484 hasConcept C2780192828 @default.
• W2040997484 hasConcept C2781406297 @default.
• W2040997484 hasConcept C71924100 @default.
• W2040997484 hasConceptScore W2040997484C121608353 @default.
• W2040997484 hasConceptScore W2040997484C126322002 @default.
• W2040997484 hasConceptScore W2040997484C126894567 @default.
• W2040997484 hasConceptScore W2040997484C134018914 @default.
• W2040997484 hasConceptScore W2040997484C141071460 @default.
• W2040997484 hasConceptScore W2040997484C142724271 @default.

• next